Navigation Links
Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival

- New Data from Phase III Intergroupe Francophone du Myelome (IFM) Trial Presented During IMW -

CAMBRIDGE, Mass., July 02, 2007 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. today reported that new data were presented on the comparative Phase III clinical trial evaluating a VELCADE based therapy in newly diagnosed multiple myeloma (MM) patients. As induction therapy prior to stem cell transplantation (SCT), the VELCADE based therapy produced a high complete remission / complete response(1) (CR) rate of 20 percent, which led to a post SCT CR rate of 43 percent. These results were substantially stronger than those of a commonly used induction chemotherapy regimen vincristine, adriamycin and dexamethasone (VAD), which served as the comparative therapy in the trial. The data showed that the VELCADE based therapy, compared to VAD, nearly doubled the CR rate as induction therapy and provided a greater than 50 percent improvement in CR rate following SCT. Achievement of CR is the goal of SCT therapy because achievement of CR increases both progression-free and overall survival. The data were presented in conjunction with the prestigious 11th International Myeloma Workshop (IMW) in Kos, Greece.

"Historically, stem cell transplantations generated similar response rates regardless of the induction therapy due to the limited efficacy of these therapies. With VELCADE, we now have a powerful agent that has consistently delivered high complete remission rates during induction and has allowed physicians to mobilize stem cells successfully. These benefits have translated to post-transplantation complete remission rates that are significantly higher than what has ever been achieved before," said Professor Jean-Luc Harousseau, M.D., Hospital Hotel-Dieu. "We know that high complete remission rates following transplantation lead to longer progression-free survival and overall survival. These data position VELCA
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
2. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
3. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
4. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
5. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
6. Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection
7. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
10. Aquavan (Fospropofol Disodium) Injection Data Presented at Digestive Disease Week 2007
11. Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting

Post Your Comments:
(Date:11/20/2009)...ov. 20 The United States Court of ...istrict Court ruling yesterday, approving a settle...AWP) pharmaceutical litigation against AstraZeneca...newscom.com/cgi-bin/prnh/20080317/AQM144LOGO ) ,...nsumers who purchased the pharmaceutical giant,s p...
(Date:11/20/2009)... Nov. 20 Cornerstone The...aceutical company focused on acquiring, developing...y for the respiratory and related markets, today r... the Food and Drug Administration ("FDA") alleging...ine HCl 10 mg, Pyrilamine Maleate 16 mg) and Decon...
(Date:11/20/2009)...l., Nov. 20 /PRNewswire-FirstCall/ -- Landauer,...r the fiscal fourth quarter and full year of 2009 ... company will host a conference call for investors...n Time. Investors may access the live call by dial...ada), or 480-629-9835 (international callers), or ...
Breaking Medicine Technology:U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 2Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 3Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Drug eluting stents better than bare metal stents for heart attack patients 58360 1Drug eluting stents better than bare metal stents for heart attack patients 58360 2NIH fellowship recipient to study disease ecology 10115 1NIH fellowship recipient to study disease ecology 10115 2NSF funds states first imaging system for UAB microscale research lab 10112 1NSF funds states first imaging system for UAB microscale research lab 10112 2
(Date:11/20/2009)...S, Nov. 20 Centene Cor...ll present at the Bank of America Merrill Lynch 20...9, at the Crowne Plaza Hotel Times Square in New Y...cember 2nd at 8:30 a.m. Eastern Time. Investors an...o webcast of Centene,s presentation at: http://ww...
(Date:11/20/2009)...EM, N.C., Nov. 20 Samue...o redefine what it means to be "happy" during the ...h a specialty in family counseling and chair of th...ty, Gladding says research shows that it is the pr... even depression during the holidays. ,, That,s...
(Date:11/20/2009)...RK, Nov. 20 SIRIUS XM R...l broadcast Doctor Radio Reports: What Every Wo...pecial hosted by veteran journalist Perri Peltz. ...20080819/NYTU044LOGO ) ,, Doctor Radio Repor...s will air November 21 live at 10:00 am ET on D...
(Date:11/20/2009)...posure to formaldehyde used for embalming in the f...risk of death from myeloid leukemia, according to ...ournal of the National Cancer Institute . , Prev...hohematopoietic malignancies and brain cancer in a...ers, all of whom may have worked with formaldehyde...
(Date:11/20/2009)...) November 20, 2009Emergency medical service (EMS)...d 350,000 cardiac arrests each year. Only 5 to 10...survive. Better quality cardiopulmonary resuscita...ay be associated with better patient outcome. The...rgest clinical research network to study prehospit...
Breaking Medicine News(10 mins):Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
...onmental issue no one's talking about," regrets C...tivist and founder of the Work Less Party, a Vanco... work week. "As a society, we're working exp...ns work more hours than anyone else in the industr...
...s? Women willing to perform oral sex can get away ...that was the experience of a porn star. She says s... the roadside tryst. The allegations have led to a...ndy Moss, declined to comment Tuesday. Highway Pat...
... gum disease periodontitis, may have an increased ... smoke. Periodontitis is an oral infection...vidence suggests the involvement of viruses as wel...er Institute, Buffalo. As part of the stud...
...of virgin birth in cartilaginous fish, after busti... an aquarium, that had only female sharks which h... The birth of the pup at Omaha's Henry Doorl...le sharks have an organ that can store sperm, but ...
...n favour of a ban on smoking in workplaces and ind... Some 88 percent of citizens in the European Uni...indoor spaces, said a study by the European Commis...lic and work places smoke-free by 2009. Wh...
...ries like Indonesia, the Unjted Nations health bod...sed efforts would be made to ensure "fair and equi...at affordable prices in the event of a pandemic." ...ed by the World Heath Assembly. The discussion o...
Other Medicine News:Health News:Work Less to Sustain Planet Earth, Say Activists 2Health News:Work Less to Sustain Planet Earth, Say Activists 3Health News:Policeman in Trouble for Seeking Oral Sex in Return for a Favour 2Health News:Men With Chronic Gum Disease at Higher Risk of Tongue Cancer 2Health News:WHO Announces Deal on Sharing Bird Flu Virus 2
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: